A lawsuit filed against a Florida assisted living facility indicates it gave an elderly resident multiple doses of the antipsychotic Invega, despite express warnings not to give the drug to dementia patients, resulting in numerous falls, injury and permanent loss of mobility.…
A new study finds that FDA warnings reduced the use of antipsychotics as chemical restraints on elderly nursing home residents, but in many cases, the facilities may have switched to other drugs which caused different health problems.…
A new study finds that Haldol and similar antipsychotics do not provide significant benefits when used to treat delirium, and may increase the risk of heart problems.…
A new study warns that antipsychotics at high doses appear to increase the risk of unexpected death for children.…
Federal investigators report that a third of foster care children in the U.S. prescribed psychotropic drugs are given no treatment plan or medical monitoring while taking the powerful medications.…
Abilify lawsuits filed in New Jersey state courts have been consolidated before one judge for pretrial proceedings.…
An AARP study warns that the use of antipsychotics as chemical restraints on elderly patients with dementia is increasing among those who do not live in nursing homes.…
Abilify lawsuits can move forward after a federal judge dismissed a motion for summary judgment by the manufacturers.…
A new report by Human Rights Watch details rampant overuse of antipsychotics in U.S. nursing homes, which are used as a form of chemical restraint on patients with dementia.…
A new study indicates that less reliance on psychoactive drugs and better staffing could help prevent many nursing home falls and fractures.…
